MK-3475 Randomized, Phase II study of MK-3475 versus Chemotherapy
Name
Merck and Company
Anticipated Amount
1 351 356.00
Activity Type
Clinical Trial
Award Type
Contract
Date
December 8, 2012 to August 29, 2014
Award Number
006135-00001
Sponsor Award Number
MK-3475-002-007
Award Contacts
Name
Cranmer,Lee D
Title
Principal Investigator
Unit
Cancer Center Division